Segment Reporting

9 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Reporting

19. Segment Reporting

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

The Company manages and aggregates its operational and financial information in accordance with two reportable segments: Rx and Consumer Health. The Rx segment consists of the Company’s prescription products. The Consumer Health segment contains the Company’s consumer healthcare products.

Select financial information for these segments is as follows:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022
	(In thousands)
Consolidated revenue:
Rx Segment	$	13,805	$	13,862	$	50,486	$	42,388
Consumer Health Segment		8,928		10,337		26,181		26,833
Consolidated revenue	$	22,733	$	24,199	$	76,667	$	69,221
Consolidated net loss:
Rx Segment	$	(5,777)	$	(52,529)	$	(10,931)	$	(88,577)
Consumer Health Segment		(1,423)		(762)		(3,663)		(4,113)
Consolidated net loss	$	(7,200)	$	(53,291)	$	(14,594)	$	(92,690)

	March 31,		June 30,
	2023		2022
	(In thousands)
Total assets:
Rx Segment	$	131,982	$	121,377
Consumer Health Segment		15,234		16,246
Consolidated assets	$	147,216	$	137,623